Prognostic Factors and Recurrence Pattern of Far-advanced Gastric Cancer with Pathologically-positive Para-aortic Lymph Nodes

被引:11
作者
Kaito, Akio [1 ,2 ]
Kinoshita, Takahiro [1 ]
Tokunaga, Masanori [1 ]
Sunagawa, Hideki [1 ]
Watanabe, Masahiro [1 ]
Sugita, Shizuki [1 ]
Tonouchi, Akiko [1 ]
Sato, Reo [1 ]
Abe, Iku [1 ]
Akimot, Tetsuo [2 ,3 ]
机构
[1] Natl Canc Ctr Hosp East, Gastr Surg Div, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan
[2] Juntendo Univ, Grad Sch Med, Tokyo, Japan
[3] Natl Canc Ctr Hosp East, Dept Radiat Oncol, Kashiwa, Chiba, Japan
关键词
Stomach neoplasms; para-aortic lymph node; extended lymphadenectomy; locoregional neoplasm recurrence; prognosis; PHASE-II TRIAL; NEOADJUVANT CHEMOTHERAPY; NODAL DISSECTION; D2; LYMPHADENECTOMY; GASTRECTOMY; SURGERY; S-1; CARCINOMA;
D O I
10.21873/anticanres.11740
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The role of para-aortic lymph node (PALN) dissection for far-advanced gastric cancer is controversial in patients with clinical PALN positivity who have responded to chemotherapy. Materials and Methods: We retrospectively analyzed long-term outcomes of patients with pathologically-positive PALNs who underwent radical gastrectomy. Results: The 3- and 5-year overall survival (OS) rates of 65 pathologically PALN-positive patients who underwent PALN dissection (n=704) were 33.8% and 21.2%, respectively. Multivariable analysis revealed the following poor prognostic factors: nodal involvement around the celiac axis (hazard ratio (HR)=4.04, 95% confidence interval (CI)=1.55-9.63), tumor diameter of >= 120 mm (HR=3.37; 95% CI=1.189.63) and >= 3 PALNs involved (HR=2.24; 95% CI=1.21-4.15). Patients with none of these factors survived significantly longer than those with any of these factors (5-year OS=87.5% versus 9.3%, respectively; p<0.001). Conclusion: Pathologically PALN-positive patients achieve long survival; however, the indications for PALN dissection should be carefully considered.
引用
收藏
页码:3685 / 3692
页数:8
相关论文
共 24 条
[1]  
Baba M, 2000, HEPATO-GASTROENTEROL, V47, P893
[2]   Tumor Site and Perigastric Nodal Status are the Most Important Predictors of Para-Aortic Nodal Involvement in Advanced Gastric Cancer [J].
de Manzoni, Giovanni ;
Di Leo, Alberto ;
Roviello, Franco ;
Marrelli, Daniele ;
Giacopuzzi, Simone ;
Minicozzi, Anna Maria ;
Verlato, Giuseppe .
ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (08) :2273-2280
[3]   Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey [J].
Dindo, D ;
Demartines, N ;
Clavien, PA .
ANNALS OF SURGERY, 2004, 240 (02) :205-213
[4]   Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer [J].
Inoue, K. ;
Nakane, Y. ;
Kogire, M. ;
Fujitani, K. ;
Kimura, Y. ;
Imamura, H. ;
Tamura, S. ;
Okano, S. ;
Kwon, A. H. ;
Kurokawa, Y. ;
Shimokawa, T. ;
Takiuchii, H. ;
Tsujinaka, T. ;
Furukawa, H. .
EJSO, 2012, 38 (02) :143-149
[5]  
Isozaki H, 1999, HEPATO-GASTROENTEROL, V46, P549
[6]   Japanese classification of gastric carcinoma: 3rd English edition [J].
Sano T. ;
Kodera Y. .
GASTRIC CANCER, 2011, 14 (02) :101-112
[7]  
Japanese Gastric Cancer Association, 2014, JAP GASTR CANC TREAT
[8]   Multicentre analysis of long-term outcome after surgical resection for gastric cancer liver metastases [J].
Kinoshita, T. ;
Kinoshita, T. ;
Saiura, A. ;
Esaki, M. ;
Sakamoto, H. ;
Yamanaka, T. .
BRITISH JOURNAL OF SURGERY, 2015, 102 (01) :102-107
[9]   Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: A multi-institutional study [J].
Kunisaki, C ;
Akiyama, H ;
Nomura, M ;
Matsuda, G ;
Otsuka, Y ;
Ono, H ;
Nagahori, Y ;
Hosoi, H ;
Takahashi, M ;
Kito, F ;
Shimada, H .
ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (05) :659-667
[10]   The clinical significance of para-aortic nodal dissection for advanced gastric cancer [J].
Morita, S. ;
Fukagawa, T. ;
Fujiwara, H. ;
Katai, H. .
EJSO, 2016, 42 (09) :1448-1454